Omada Health CEO Duffy sells 12,944 shares

The options were fully vested and exercisable, with expiration dates of August 21, 2029, and May 5, 2031.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. Chief Executive Officer Sean P. Duffy exercised options for 12,944 shares at $5.82 and 4,314 shares at $8.28 on October 1, 2026, acquiring those amounts of common stock and selling them the same day. He sold 12,944 shares at a weighted-average price of $20.6082 and 4,314 shares at $20.90. The common-stock acquisitions and sales were made under a Rule 10b5-1 trading plan adopted March 13, 2026. A separate indirect holding of 851,659 shares is held in family trusts; Duffy disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Exercise and Sale: 17,258 shares ($246K approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Duffy Sean P.

Role Chief Executive Officer

Sold 17,258 shs ($357K)

Approx. gross sale proceeds $357K

Approx. exercise cost $111K

Approx. pre-tax spread $246K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F4	12,944	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^F4	4,314	$0.00	$0.00
Exercise	Common Stock ^F1	12,944	$5.82	$75K
Exercise	Common Stock ^F1	4,314	$8.28	$36K
Sale	Common Stock ^{F1, F2}	12,944	$20.6082	$267K
Sale	Common Stock ^F1	4,314	$20.90	$90K
holding	Common Stock ^F3	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 218,499 contracts (Direct); Common Stock — 382,594 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)

Footnotes (4)

F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
F2. This transaction was executed in multiple trades at prices ranging from $20.11 to $20.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
F4. 100% of the shares subject to the option are fully vested and exercisable.

Key Figures

Shares acquired on option exercise: 12,944 shares Option exercise price: $5.82 per share Shares acquired on option exercise: 4,314 shares +4 more

7 metrics

Shares acquired on option exercise 12,944 shares October 1, 2026

Option exercise price $5.82 per share Options covering 12,944 shares; October 1, 2026

Shares acquired on option exercise 4,314 shares October 1, 2026

Option exercise price $8.28 per share Options covering 4,314 shares; October 1, 2026

Shares sold 12,944 shares Weighted-average sale price $20.6082 per share; October 1, 2026

Shares sold 4,314 shares Sale price $20.90 per share; October 1, 2026

Indirect family-trust holdings 851,659 shares Reported October 1, 2026

Key Terms

10b5-1 trading plan, weighted average price, fully vested and exercisable, pecuniary interest

4 terms

10b5-1 trading plan regulatory

"pursuant to a 10b5-1 trading plan adopted"

A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.

weighted average price financial

"price reported above reflects the weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

fully vested and exercisable financial

"100% of the shares subject to the option are fully vested and exercisable"

pecuniary interest financial

"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OMDA shares did CEO Sean P. Duffy sell, and at what prices?

Sean P. Duffy sold 12,944 shares at a weighted-average price of $20.6082 and 4,314 shares at $20.90 on October 1, 2026. The first sale was executed in multiple trades priced from $20.11 to $20.97. The common-stock acquisitions and sales were made under a Rule 10b5-1 plan adopted March 13, 2026.

When do Sean P. Duffy's OMDA options expire?

The options covering 12,944 shares expire August 21, 2029, and those covering 4,314 shares expire May 5, 2031. The options were fully vested and exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/05/2026 - 05:07 PM Accepted by SEC EDGAR 10/05/2026 - 05:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2026		M⁽¹⁾		12,944	A	$5.82	395,538	D
Common Stock	10/01/2026		M⁽¹⁾		4,314	A	$8.28	399,852	D
Common Stock	10/01/2026		S⁽¹⁾		12,944	D	$20.6082⁽²⁾	386,908	D
Common Stock	10/01/2026		S⁽¹⁾		4,314	D	$20.9	382,594	D
Common Stock								851,659	I	See footnote⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$5.82	10/01/2026		M			12,944	⁽⁴⁾	08/21/2029	Common Stock	12,944	$0	116,595	D
Stock Option (Right to Buy)	$8.28	10/01/2026		M			4,314	⁽⁴⁾	05/05/2031	Common Stock	4,314	$0	101,904	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $20.11 to $20.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

4. 100% of the shares subject to the option are fully vested and exercisable.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR